Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells

European Journal of Pharmacology

Volumn 831, Issue , 2018, Pages 52-59

  Li, Meng ^a   van Esch, Betty C A M ^a,b   Wagenaar, Gerry T M ^c,d   Garssen, Johan ^a,b   Folkerts, Gert ^a   Henricks, Paul A J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b DANONE NUTRICIA RESEARCH   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

HDACs; Inflammation, GPCRs; MAPK; NF B; SCFA

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; FREE FATTY ACID RECEPTOR 2; FREE FATTY ACID RECEPTOR 3; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 109A; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROPIONIC ACID; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFLAMMATORY AGENT; AUTACOID; CELL SURFACE RECEPTOR; FFAR3 PROTEIN, HUMAN; G-PROTEIN COUPLED RECEPTOR 43, HUMAN; HCAR2 PROTEIN, HUMAN; HISTONE DEACETYLASE INHIBITOR; NICOTINIC RECEPTOR; VOLATILE FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CELL TRANSPORT; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOTHELIUM CELL; ENZYME INHIBITION; EOSINOPHIL; FAT INTAKE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MAPK SIGNALING; MOLECULAR MECHANICS; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECT; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ENDOTHELIAL CELLS; FATTY ACIDS, VOLATILE; HISTONE DEACETYLASE INHIBITORS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATION MEDIATORS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION;

EID: 85047180733     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2018.05.003     Document Type: Article

References (113)

1. Aguilar, E.C., Leonel, A.J., Teixeira, L.G., Silva, A.R., Silva, J.F., Pelaez, J.M., Capettini, L.S., Lemos, V.S., Santos, R.A., Alvarez-Leite, J.I., Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFkappaB activation. Nutr. Metab. Cardiovasc. Dis. 24 (2014), 606–613.
2. Anderson, J.W., Baird, P., Davis, R.H. Jr., Ferreri, S., Knudtson, M., Koraym, A., Waters, V., Williams, C.L., Health benefits of dietary fiber. Nutr. Rev. 67 (2009), 188–205.
3. Andrade-Oliveira, V., Amano, M.T., Correa-Costa, M., Castoldi, A., Felizardo, R.J., de Almeida, D.C., Bassi, E.J., Moraes-Vieira, P.M., Hiyane, M.I., Rodas, A.C., Peron, J.P., Aguiar, C.F., Reis, M.A., Ribeiro, W.R., Valduga, C.J., Curi, R., Vinolo, M.A., Ferreira, C.M., Camara, N.O., Gut bacteria products prevent AKI induced by ischemia-reperfusion. J. Am. Soc. Nephrol. 26 (2015), 1877–1888.
4. Ang, Z., Er, J.Z., Tan, N.S., Lu, J., Liou, Y.C., Grosse, J., Ding, J.L., Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists. Sci. Rep., 6, 2016, 34145.
5. Aoyama, M., Kotani, J., Usami, M., Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition 26 (2010), 653–661.
6. Ashburner, B.P., Westerheide, S.D., Baldwin, A.S. Jr., Thep65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21 (2001), 7065–7077.
7. Baeuerle, P.A., Baichwal, V.R., NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65 (1997), 111–137.
8. Bohmig, G.A., Krieger, P.M., Saemann, M.D., Wenhardt, C., Pohanka, E., Zlabinger, G.J., n-butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids. Immunology 92 (1997), 234–243.
9. Bolognini, D., Tobin, A.B., Milligan, G., Moss, C.E., The pharmacology and function of receptors for short-chain fatty acids. Mol. Pharmacol. 89 (2016), 388–398.
10. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., Muir, A.I., Wigglesworth, M.J., Kinghorn, I., Fraser, N.J., Pike, N.B., Strum, J.C., Steplewski, K.M., Murdock, P.R., Holder, J.C., Marshall, F.H., Szekeres, P.G., Wilson, S., Ignar, D.M., Foord, S.M., Wise, A., Dowell, S.J., The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278 (2003), 11312–11319.
11. Casey, L.C., Balk, R.A., Bone, R.C., Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119 (1993), 771–778.
12. Chai, J.T., Digby, J.E., Choudhury, R.P., GPR109A and vascular inflammation. Curr. Atheroscler. Rep., 15, 2013, 352.
13. Chang, P.V., Hao, L., Offermanns, S., Medzhitov, R., The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. USA 111 (2014), 2247–2252.
14. Chen, L., Fischle, W., Verdin, E., Greene, W.C., Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293 (2001), 1653–1657.
15. Chen, X., Barozzi, I., Termanini, A., Prosperini, E., Recchiuti, A., Dalli, J., Mietton, F., Matteoli, G., Hiebert, S., Natoli, G., Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl. Acad. Sci. USA 109 (2012), E2865–E2874.
16. Cheng, F., Lienlaf, M., Perez-Villarroel, P., Wang, H.W., Lee, C., Woan, K., Woods, D., Knox, T., Bergman, J., Pinilla-Ibarz, J., Kozikowski, A., Seto, E., Sotomayor, E.M., Villagra, A., Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells. Mol. Immunol. 60 (2014), 44–53.
17. Cheng, F., Lienlaf, M., Wang, H.W., Perez-Villarroel, P., Lee, C., Woan, K., Rock-Klotz, J., Sahakian, E., Woods, D., Pinilla-Ibarz, J., Kalin, J., Tao, J., Hancock, W., Kozikowski, A., Seto, E., Villagra, A., Sotomayor, E.M., A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs. J. Immunol. 193 (2014), 2850–2862.
18. Ciarlo, E., Savva, A., Roger, T., Epigenetics in sepsis: targeting histone deacetylases. Int. J. Antimicrob. Agents 42 (2013), Suppl, S8–12.
19. Czepiel, J., Biesiada, G., Brzozowski, T., Ptak-Belowska, A., Perucki, W., Birczynska, M., Jurczyszyn, A., Strzalka, M., Targosz, A., Garlicki, A., The role of local and systemic cytokines in patients infected with Clostridium difficile. J. Physiol. Pharmacol. 65 (2014), 695–703.
20. Dauphinee, S.M., Karsan, A., Lipopolysaccharide signaling in endothelial cells. Lab. Investig. 86 (2006), 9–22.
21. Davie, J.R., Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133 (2003), 2485s–2493s.
22. Didonna, A., Opal, P., The promise and perils of HDAC inhibitors in neurodegeneration. Ann. Clin. Transl. Neurol. 2 (2015), 79–101.
23. Digby, J.E., Martinez, F., Jefferson, A., Ruparelia, N., Chai, J., Wamil, M., Greaves, D.R., Choudhury, R.P., Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 669–676.
24. Esposito, K., Giugliano, D., Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur. Heart J. 27 (2006), 15–20.
25. Fukumori, R., Sugino, T., Hasegawa, Y., Kojima, M., Kangawa, K., Obitsu, T., Taniguchi, K., Plasma ghrelin concentration is decreased by short chain fatty acids in wethers. Domest. Anim. Endocrinol. 41 (2011), 50–55.
26. Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., Pei, G., Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 14 (2004), 303–317.
27. Glauser, M.P., The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 52:Suppl. 2 (1996), S9–S17.
28. Gray, S.G., Ekstrom, T.J., The human histone deacetylase family. Exp. Cell Res. 262 (2001), 75–83.
29. Hadi, H.A., Carr, C.S., Al Suwaidi, J., Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc. Health Risk Manag. 1 (2005), 183–198.
30. Halili, M.A., Andrews, M.R., Labzin, L.I., Schroder, K., Matthias, G., Cao, C., Lovelace, E., Reid, R.C., Le, G.T., Hume, D.A., Irvine, K.M., Matthias, P., Fairlie, D.P., Sweet, M.J., Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. J. Leukoc. Biol. 87 (2010), 1103–1114.
31. Halnes, I., Baines, K.J., Berthon, B.S., MacDonald-Wicks, L.K., Gibson, P.G., Wood, L.G., Soluble fibre meal challenge reduces airway inflammation and expression of GPR43 and GPR41 in asthma. Nutrients, 9, 2017, 57.
32. Hara, T., Kimura, I., Inoue, D., Ichimura, A., Hirasawa, A., Free fatty acid receptors and their role in regulation of energy metabolism. Rev. Physiol. Biochem. Pharmacol. 164 (2013), 77–116.
33. Henricks, P.A.J., Nijkamp, F.P., Pharmacological modulation of cell adhesion molecules. Eur. J. Pharmacol. 344 (1998), 1–13.
34. Hoffman, J.B., Petriello, M.C., Hennig, B., Butyrate modulates Cav-1 and its binding partner AhR, leading to differential Cyp1a1 and Cyp1b1 gene expression in vascular endothelial cells. FASEB J., 30, 2016, 1175.
35. Huang, W., Zhou, L., Guo, H., Xu, Y., Xu, Y., The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response. Metabolism 68 (2017), 20–30.
36. Iantorno, M., Campia, U., Di Daniele, N., Nistico, S., Forleo, G.B., Cardillo, C., Tesauro, M., Obesity, inflammation and endothelial dysfunction. J. Biol. Regul. Homeost. Agents 28 (2014), 169–176.
37. Ince, C., Mayeux, P.R., Nguyen, T., Gomez, H., Kellum, J.A., Ospina-Tascon, G.A., Hernandez, G., Murray, P., De Backer, D., The endothelium in sepsis. Shock 45 (2016), 259–270.
38. Inoue, K., Kobayashi, M., Yano, K., Miura, M., Izumi, A., Mataki, C., Doi, T., Hamakubo, T., Reid, P.C., Hume, D.A., Yoshida, M., Aird, W.C., Kodama, T., Minami, T., Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. Arterioscler. Thromb. Vasc. Biol. 26 (2006), 2652–2659.
39. Jeong, Y., Du, R., Zhu, X., Yin, S., Wang, J., Cui, H., Cao, W., Lowenstein, C.J., Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1. J. Leukoc. Biol. 95 (2014), 651–659.
40. Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A., Kimura, I., Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7 (2015), 2839–2849.
41. Katoh, K., Tsuda, T., Effects of intravenous injection of butyrate on the exocrine pancreatic secretion in guinea pigs. Comp. Biochem. Physiol. A Comp. Physiol. 87 (1987), 569–572.
42. Kendrick, S.F., O'Boyle, G., Mann, J., Zeybel, M., Palmer, J., Jones, D.E., Day, C.P., Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology 51 (2010), 1988–1997.
43. Kim, H.J., Bae, S.C., Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am. J. Transl. Res. 3 (2011), 166–179.
44. Kim, M.H., Kang, S.G., Park, J.H., Yanagisawa, M., Kim, C.H., Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145 (2013), 396–406.
45. Kim, S., Kim, J.H., Park, B.O., Kwak, Y.S., Perspectives on the therapeutic potential of short-chain fatty acid receptors. BMB Rep. 47 (2014), 173–178.
46. Kumar, A., Lin, Z., SenBanerjee, S., Jain, M.K., Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases. Mol. Cell. Biol. 25 (2005), 5893–5903.
47. Le Poul, E., Loison, C., Struyf, S., Springael, J.Y., Lannoy, V., Decobecq, M.E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., Parmentier, M., Detheux, M., Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278 (2003), 25481–25489.
48. Lee, D.Y., Lee, C.I., Lin, T.E., Lim, S.H., Zhou, J., Tseng, Y.C., Chien, S., Chiu, J.J., Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow. Proc. Natl. Acad. Sci. USA 109 (2012), 1967–1972.
49. Lee, S.U., In, H.J., Kwon, M.S., Park, B.O., Jo, M., Kim, M.O., Cho, S., Lee, S., Lee, H.J., Kwak, Y.S., Kim, S., beta-arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-kappaB. Biol. Pharm. Bull. 36 (2013), 1754–1759.
50. Li, M., Van Esch, B.E.C., Henricks, P.A.J., Garssen, J., Folkerts, G., Time and concentration dependent effects of short chain fatty acids on lipopolysaccharide-or tumor necrosis factor α-induced endothelial activation. Front. Pharmacol., 9, 2018, 233.
51. Li, Q., Sarna, S.K., Nitric oxide modifies chromatin to suppress ICAM-1 expression during colonic inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 303 (2012), G103–G110.
52. Li, S., Flint, A., Pai, J.K., Forman, J.P., Hu, F.B., Willett, W.C., Rexrode, K.M., Mukamal, K.J., Rimm, E.B., Dietary fiber intake and mortality among survivors of myocardial infarction: prospective cohort study. BMJ, 348, 2014, g2659.
53. Licciardi, P.V., Ververis, K., Karagiannis, T.C., Histone deacetylase inhibition and dietary short-chain fatty acids. ISRN Allergy, 2011, 2011, 869647.
54. Liu, S.F., Malik, A.B., NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 290 (2006), L622–L645.
55. Macfarlane, S., Cleary, S., Bahrami, B., Reynolds, N., Macfarlane, G.T., Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment. Pharmacol. Ther. 38 (2013), 804–816.
56. Madge, L.A., Pober, J.S., TNF signaling in vascular endothelial cells. Exp. Mol. Pathol. 70 (2001), 317–325.
57. Martin, P.M., Ananth, S., Cresci, G., Roon, P., Smith, S., Ganapathy, V., Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Mol. Vis. 15 (2009), 362–372.
58. Masui, R., Sasaki, M., Funaki, Y., Ogasawara, N., Mizuno, M., Iida, A., Izawa, S., Kondo, Y., Ito, Y., Tamura, Y., Yanamoto, K., Noda, H., Tanabe, A., Okaniwa, N., Yamaguchi, Y., Iwamoto, T., Kasugai, K., G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm. Bowel Dis. 19 (2013), 2848–2856.
59. Menzel, T., Luhrs, H., Zirlik, S., Schauber, J., Kudlich, T., Gerke, T., Gostner, A., Neumann, M., Melcher, R., Scheppach, W., Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1. Inflamm. Bowel Dis. 10 (2004), 122–128.
60. Mestas, J., Ley, K., Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc. Med. 18 (2008), 228–232.
61. Miller, S.J., Zaloga, G.P., Hoggatt, A.M., Labarrere, C., Faulk, W.P., Short-chain fatty acids modulate gene expression for vascular endothelial cell adhesion molecules. Nutrition 21 (2005), 740–748.
62. Miyoshi, M., Sakaki, H., Usami, M., Iizuka, N., Shuno, K., Aoyama, M., Usami, Y., Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats. Clin. Nutr. 30 (2011), 252–258.
63. Miyoshi, M., Usami, M., Ohata, A., Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells. Nutrition 24 (2008), 1189–1198.
64. Morrison, D.J., Preston, T., Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7 (2016), 189–200.
65. Ni, Y.-F., Wang, J., Yan, X.-L., Tian, F., Zhao, J.-B., Wang, Y.-J., Jiang, T., Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice. Respir. Res., 11, 2010, 33.
66. Ogawa, H., Rafiee, P., Fisher, P.J., Johnson, N.A., Otterson, M.F., Binion, D.G., Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem. Biophys. Res. Commun. 309 (2003), 512–519.
67. Ohira, H., Fujioka, Y., Katagiri, C., Mamoto, R., Aoyama-Ishikawa, M., Amako, K., Izumi, Y., Nishiumi, S., Yoshida, M., Usami, M., Ikeda, M., Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages. J. Atheroscler. Thromb. 20 (2013), 425–442.
68. Ordovas, J.M., Smith, C.E., Epigenetics and cardiovascular disease. Nat. Rev. Cardiol. 7 (2010), 510–519.
69. Pahl, H.L., Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999), 6853–6866.
70. Palladino, M.A., Bahjat, F.R., Theodorakis, E.A., Moldawer, L.L., Anti-TNF-alpha therapies: the next generation. Nat. Rev. Drug Discov. 2 (2003), 736–746.
71. Paulus, P., Jennewein, C., Zacharowski, K., Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?. Biomarkers 16:Suppl. 1 (2011), S11–S21.
72. Paz-Priel, I., Houng, S., Dooher, J., Friedman, A.D., C/ebpalpha and C/ebpalpha oncoproteins regulate nfkb1 and displace histone deacetylases from NF-kappaB p50 homodimers to induce NF-kappaB target genes. Blood 117 (2011), 4085–4094.
73. Pluznick, J., A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes 5 (2014), 202–207.
74. Poralla, L., Stroh, T., Erben, U., Sittig, M., Liebig, S., Siegmund, B., Glauben, R., Histone deacetylase 5 regulates the inflammatory response of macrophages. J. Cell. Mol. Med. 19 (2015), 2162–2171.
75. Rafehi, H., Balcerczyk, A., Lunke, S., Kaspi, A., Ziemann, M., Harikrishnan, K.N., Okabe, J., Khurana, I., Ooi, J., Khan, A.W., Du, X., Chang, L., Haviv, I., Keating, S., Karagiannis, T., El-Osta, A., Regulation of inflammatory gene expression by histone acetylation and HDAC inhibition in human aortic endothelial cells. Atherosclerosis 241, e6.
76. Randolph, G.J., The fate of monocytes in atherosclerosis. J. Thromb. Haemost. 7 (2009), 28–30.
77. Reichert, N., Choukrallah, M.A., Matthias, P., Multiple roles of class I HDACs in proliferation, differentiation, and development. Cell. Mol. Life Sci. 69 (2012), 2173–2187.
78. Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X.C., Chanson, A.L., Reymond, M.K., Miconnet, I., Schrenzel, J., Francois, P., Calandra, T., Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117 (2011), 1205–1217.
79. Ropero, S., Esteller, M., The role of histone deacetylases (HDACs) in human cancer. Mol. Oncol. 1 (2007), 19–25.
80. Ross, R., Atherosclerosis–an inflammatory disease. N. Engl. J. Med. 340 (1999), 115–126.
81. Rubanyi, G.M., The role of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol. 22:Suppl. 4 (1993), S1–S14.
82. Saemann, M.D., Bohmig, G.A., Osterreicher, C.H., Burtscher, H., Parolini, O., Diakos, C., Stockl, J., Horl, W.H., Zlabinger, G.J., Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 14 (2000), 2380–2382.
83. Schaub, A., Futterer, A., Pfeffer, K., PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur. J. Immunol. 31 (2001), 3714–3725.
84. Schilderink, R., Verseijden, C., de Jonge, W.J., Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front. Immunol., 4, 2013, 226.
85. Seljeset, S., Siehler, S., Receptor-specific regulation of ERK1/2 activation by members of the “free fatty acid receptor” family. J. Recept. Signal Transduct. Res. 32 (2012), 196–201.
86. Sina, C., Gavrilova, O., Forster, M., Till, A., Derer, S., Hildebrand, F., Raabe, B., Chalaris, A., Scheller, J., Rehmann, A., Franke, A., Ott, S., Hasler, R., Nikolaus, S., Folsch, U.R., Rose-John, S., Jiang, H.P., Li, J., Schreiber, S., Rosenstiel, P., G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol. 183 (2009), 7514–7522.
87. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P.D., Manicassamy, S., Munn, D.H., Lee, J.R., Offermanns, S., Ganapathy, V., Activation of the receptor (GPR109a) for niacin and the commensal metabolite butyrate suppresses colonic inflammation and carcinogenesis. Immunity 40 (2014), 128–139.
88. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., Glickman, J.N., Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
89. Suckow, A.T., Briscoe, C.P., Key questions for translation of FFA receptors: from pharmacology to medicines. Handb. Exp. Pharmacol. 236 (2017), 101–131.
90. Sun, M., Wu, W., Liu, Z., Cong, Y., Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J. Gastroenterol. 52 (2017), 1–8.
91. Swirski, F.K., Nahrendorf, M., Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339 (2013), 161–166.
92. Tan, J., McKenzie, C., Potamitis, M., Thorburn, A.N., Mackay, C.R., Macia, L., The role of short-chain fatty acids in health and disease. Adv. Immunol. 121 (2014), 91–119.
93. Tazoe, H., Otomo, Y., Kaji, I., Tanaka, R., Karaki, S.I., Kuwahara, A., Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J. Physiol. Pharmacol. 59:Suppl. 2 (2008), S251–S262.
94. Tedelind, S., Westberg, F., Kjerrulf, M., Vidal, A., Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol. 13 (2007), 2826–2832.
95. Thorburn, A.N., Macia, L., Mackay, C.R., Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 40 (2014), 833–842.
96. Threapleton, D.E., Greenwood, D.C., Evans, C.E., Cleghorn, C.L., Nykjaer, C., Woodhead, C., Cade, J.E., Gale, C.P., Burley, V.J., Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ, 347, 2013, f6879.
97. Topping, D.L., Clifton, P.M., Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81 (2001), 1031–1064.
98. Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L.P., Harris, N.L., Marsland, B.J., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20 (2014), 159–166.
99. Ulven, T., Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets. Front. Endocrinol., 3, 2012, 111.
100. Usami, M., Kishimoto, K., Ohata, A., Miyoshi, M., Aoyama, M., Fueda, Y., Kotani, J., Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr. Res. 28 (2008), 321–328.
101. Vinolo, M.A., Ferguson, G.J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly, Y.M., Stephens, L., Hawkins, P.T., Curi, R., SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One, 6, 2011, e21205.
102. Vinolo, M.A., Hatanaka, E., Lambertucci, R.H., Newsholme, P., Curi, R., Effects of short chain fatty acids on effector mechanisms of neutrophils. Cell Biochem. Funct. 27 (2009), 48–55.
103. Vinolo, M.A., Rodrigues, H.G., Hatanaka, E., Hebeda, C.B., Farsky, S.H., Curi, R., Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clin. Sci. 117 (2009), 331–338.
104. Vinolo, M.A., Rodrigues, H.G., Hatanaka, E., Sato, F.T., Sampaio, S.C., Curi, R., Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22 (2011), 849–855.
105. Vinolo, M.A., Rodrigues, H.G., Nachbar, R.T., Curi, R., Regulation of inflammation by short chain fatty acids. Nutrients 3 (2011), 858–876.
106. Voltolini, C., Battersby, S., Etherington, S.L., Petraglia, F., Norman, J.E., Jabbour, H.N., A novel antiinflammatory role for the short-chain fatty acids in human labor. Endocrinology 153 (2012), 395–403.
107. Wu, J., Zhou, Z., Hu, Y., Dong, S., Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. J. Genet. Genom. 39 (2012), 375–384.
108. Xu, S.S., Alam, S., Margariti, A., Epigenetics in vascular disease - therapeutic potential of new agents. Curr. Vasc. Pharmacol. 12 (2014), 77–86.
109. Yu, X., Shahir, A.M., Sha, J., Feng, Z., Eapen, B., Nithianantham, S., Das, B., Karn, J., Weinberg, A., Bissada, N.F., Ye, F., Short-chain fatty acids from periodontal pathogens suppress histone deacetylases, EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication. J. Virol. 88 (2014), 4466–4479.
110. Zapolska-Downar, D., Naruszewicz, M., Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation. J. Physiol. Pharmacol. 60 (2009), 123–131.
111. Zapolska-Downar, D., Siennicka, A., Kaczmarczyk, M., Kolodziej, B., Naruszewicz, M., Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha. J. Nutr. Biochem. 15 (2004), 220–228.
112. Zhong, H., May, M.J., Jimi, E., Ghosh, S., The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9 (2002), 625–636.
113. Zhou, B., Margariti, A., Zeng, L., Xu, Q., Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc. Res. 90 (2011), 413–420.